Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA promoter regions are essential regulatory segments of DNA located typically upstream of the transcription start site of a gene (National Human Genome Research Institute, 2023). Their primary biological function is to serve as a scaffold for the assembly of the transcription pre-initiation complex, including RNA polymerase and various transcription factors (Nature Education, 2014). By controlling the frequency and timing of transcription, promoters act as the fundamental gatekeepers of gene expression. In many diseases, particularly oncology, the dysregulation of promoter activity through genetic mutations or epigenetic modifications like hypermethylation leads to the silencing of tumor suppressor genes (Herman & Baylin, 2003). Conversely, promoter hypomethylation or mutations in specific elements, such as the TERT promoter, can drive the overexpression of oncogenes. Therapeutic strategies targeting these regions include small molecules like Mithramycin A, which binds to GC-rich sequences to displace transcription factors, and epigenetic drugs like Decitabine that inhibit DNA methyltransferases to reactivate silenced promoters (Gupta et al., 2017). Furthermore, advanced technologies such as CRISPR-mediated transcriptional modulation (CRISPRa/i) are being developed to target specific promoters for the treatment of genetic disorders (Puckett et al., 2017).
Drugs targeting DNA promoter regions typically function by binding to specific DNA sequences (such as GC-rich regions) to physically displace transcription factors, intercalating into the DNA helix to prevent RNA polymerase progression, or inhibiting enzymes like DNA methyltransferases to alter the epigenetic methylation state of the promoter (Gupta et al., 2017; Herman & Baylin, 2003).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA promoter region.